LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.19
+0.00 (+0.00%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+7,268.4% upside
Low Target
$9.32
Average Target
$14.00
High Target
$16.42
Current Price
$0.19
Current
$0.19
$0.19
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Scenario Analysis
Bear Case
$9.32
4,805.3%
Low target
Base Case
$14.00
+7,268.4%
Avg target
Bull Case
$16.42
+8,542.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$14.00
+114.4% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-1.66
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals